(NUS) Nu Skin Enterprises - Ratings and Ratios

Nu Skin Enterprises, Inc. operates as a global leader in the development, manufacturing, and distribution of innovative beauty and wellness products. The companys product portfolio includes advanced skin care devices, such as the ageLOC LumiSpa and ageLOC LumiSpa iO, as well as topical skin care solutions under the nutricentials brand. Its wellness offerings encompass nutritional supplements like LifePak, weight management systems such as ageLOC TR90, and collagen-based products like Beauty Focus Collagen+. The company is committed to research and development, focusing on cutting-edge skin care and nutritional technologies. Products are marketed under the Nu Skin, Pharmanex, and ageLOC brands, distributed through a combination of retail stores, e-commerce platforms, and a network of independent sales partners. Established in 1984, Nu Skin is headquartered in Provo, Utah, and has built a reputation for integrating science and technology into its product lines. Web URL: https://www.nuskin.com

From a financial perspective, Nu Skin Enterprises, Inc. (NYSE:NUS) currently trades at $7.96 per share, with a market capitalization of $384.36 million. The stock exhibits moderate trading activity, with an average 20-day volume of 851,681 shares. Its price action is influenced by key technical indicators, including a 20-day Simple Moving Average (SMA) of $7.00 and a 50-day SMA of $6.92, suggesting recent upward momentum. However, the 200-day SMA of $8.55 indicates that the stock is trading below its long-term average. The Average True Range (ATR) of 0.47 reflects moderate volatility. Fundamental analysis highlights a price-to-book (P/B) ratio of 0.60, signaling undervaluation relative to book value, and a price-to-sales (P/S) ratio of 0.22, indicating a low valuation relative to revenue. However, the return on equity (RoE) stands at -22.50%, raising concerns about profitability and shareholder value creation.